Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

There is no fulltext present in this item.

Title:	Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
Author(s):	Gommans, D.H.F. ; Nas, J. ; Pinto-Sietsma, S.J.; Koop, Y. ; Konst, R.E. ; Mensink, F.B. ; Aarts, G.W.A. ; Konijnenberg, L.S.F. ; Cortenbach, K.R. ; Verhaert, D.V.M. ; Thannhauser, J. ; Mol, J.H.Q. ; Rooijakkers, M.J.P. ; Vos, J.L. ; Rumund, A. van ; Vart, P. ; Hassing, R.J.; Cornel, J.H. ; Jager, C.P.C. de; Heuvel, M. van den ; Hoeven, J.G. van der ; Royen, N. van ; Kimmenade, R.R.J. van
Publication year:	2020
Source:	American Heart Journal, vol. 226, (2020), pp. 60-68
ISSN:	0002-8703
DOI:	https://doi.org/10.1016/j.ahj.2020.05.010
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/224636
Display more details
Subject:	Radboudumc 11: Renal disorders RIHS: Radboud Institute for Health Sciences Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences Radboudumc 16: Vascular damage RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Cardiology Tumorimmunology Neurology Health Evidence Internal Medicine Radboudumc Extern Pulmonary Diseases Intensive Care
Journal title:	American Heart Journal
Volume:	vol. 226
Page start:	p. 60
Page end:	p. 68